NASDAQ:LITS

Mei Pharma . Common Stock Stock Forecast

etoro logo Buy LITS
*Your capital is at risk
$0.87
-0.0374 (-4.12%)
At Close: Aug 10, 2026

Should you buy LITS stock?

Last updated:

Based on market data through , StockInvest.us rates Mei Pharma, Inc. Common Stock (LITS) as a Sell Candidate with a technical score of -4.53 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 6.34%
  • 3-month trend forecast Down 9.21%
  • Sell Candidate -4.53
AI Analysis AI Analysis of LITS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add LITS to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Mei Pharma, Inc. Common Stock stock price ended at $0.87 on Monday, after losing 4.12%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Aug 06, 2026 Loss -6.34%

The Mei Pharma, Inc. Common Stock stock price fell by -4.12% on the last day (Monday, 10th Aug 2026) from $0.91 to $0.87. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 8.20% from a day low at $0.85 to a day high of $0.92. The price has fallen in 7 of the last 10 days and is down by -10.9% for this period. Volume has increased on the last day by 32 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 199 thousand shares were bought and sold for approximately $173.08 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.21% during the next 3 months and, with a 90% probability hold a price between $0.612 and $0.92 at the end of this 3-month period.

LITS Signals & Forecast

There are few to no technical positive signals at the moment. The Mei Pharma, Inc. Common Stock stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.94 and $0.95. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 22, 2026, and so far it has fallen -15.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Mei Pharma, Inc. Common Stock gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Mei Pharma, Inc. Common Stock stock

Mei Pharma, Inc. Common Stock finds support from accumulated volume at $0.86 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0697 between high and low, or 8.20%. For the last week, the stock has had daily average volatility of 6.66%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LITS) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Mei Pharma, Inc. Common Stock to open at $0.88, and during the day (based on 14 day Average True Range), to move between $0.84 and $0.90, which gives a possible trading interval of +/-$0.0605 (+/-7.21%) up or down from last closing price. If Mei Pharma, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 7.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.86 (0.68%) than the resistance at $0.92 (5.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Mei Pharma, Inc. Common Stock stock A Buy?

Mei Pharma, Inc. Common Stock holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.530 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.88 ( 1.15%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

LITS Performance

Trading levels for LITS

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.95 9.16%
R2 0.92 6.10%
R1 0.91 4.21%
Price 0.87
S1 0.85 -1.91%
S2 0.84 -3.80%
S3 0.81 -6.86%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.07 22.97%
R2 1.04 18.95%
R1 0.92 5.73%
Price 0.87
S1 0.86 -0.678%
S2 0.82 -6.22%
S3 0.749 -13.94%

LITS Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Nov 16, 2023 Nov 16, 2023 Dec 06, 2023 $1.75 0%

FAQ

What is the symbol for Mei Pharma, Inc. Common Stock Stock and on which exchange is it traded?
The symbol for Mei Pharma, Inc. Common Stock is LITS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Mei Pharma, Inc. Common Stock Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Mei Pharma, Inc. Common Stock (LITS) as a Sell Candidate with a technical score of -4.53 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Aug 06, 2026, the price has fallen 6.34%. The current 3-month trend forecast projects a fall of 9.21%.

How to buy Mei Pharma, Inc. Common Stock Stock?
Mei Pharma, Inc. Common Stock Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Mei Pharma, Inc. Common Stock Stock.

What's the current price of Mei Pharma, Inc. Common Stock Stock?
As of the end of day on the Aug 10, 2026, the price of an Mei Pharma, Inc. Common Stock (LITS) share was $0.87.

What is the 52-week high and low for Mei Pharma, Inc. Common Stock Stock?
The 52-week high for Mei Pharma, Inc. Common Stock Stock is $4.73 and the 52-week low is $0.689.

What is the market capitalization of Mei Pharma, Inc. Common Stock Stock?
As of the Aug 10, 2026, the market capitalization of Mei Pharma, Inc. Common Stock is 29.605M.

When is the next earnings date for Mei Pharma, Inc. Common Stock?
The upcoming earnings date for Mei Pharma, Inc. Common Stock is Sep 18, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE